C annabis (derived from the ubiquitous plant, Cannabis sativa, and also known as marijuana) is the most widely used illicit drug worldwide, as well as the second most commonly smoked substance after tobacco, with an estimated 166 million users (3.9% of 15-64 yr olds) [1]. Its wide popularity is due to the euphoric effects of its major psychoactive ingredient, D 9-tetrahydrocannabinol (THC). Since the gas and particulate phase constituents of the smoke of marijuana are at least qualitatively similar to those of tobacco, the major exception being the nicotine in tobacco and the ,60 cannabinoid (THC-like) components in marijuana [2,3], there has long been concern that regular smoking of marijuana might increase the risk of developing chronic airflow obstruction and chronic obstructive pulmonary disease (COPD), by analogy with the well-known detrimental effects of tobacco. Several studies have documented that smokers of marijuana, even in the absence of tobacco smoking, show a higher prevalence of symptoms of chronic bronchitis than nonsmokers [4][5][6][7]. However, the association between marijuana smoking and airflow obstruction is less clear. Several groups of investigators have addressed the latter question by measuring lung function in convenience samples or stratified random population samples of users and nonusers of marijuana and/ or tobacco both cross-sectionally [4][5][6][8][9][10] and longitudinally [11][12][13]. The most recent study of the possible association of marijuana use with lung function abnormality appears in this issue of the European Respiratory Journal [14].Previously published studies have yielded conflicting results relating to marijuana use and lung function. An early crosssectional study of 74 young (mean age 24 yrs) habitual marijuana smokers showed no differences in either spirometric indices or sensitive measures of small airways function (closing volume or percentage change in nitrogen concentration between 750 and 1,250 mL of expired volume (DN 2 750-1250)) among marijuana users compared with non-marijuana smoking controls matched on age and tobacco smoking [8]. Interestingly, however, the 50 non-tobacco-smoking marijuana smokers (MSs) exhibited airway resistances (Raw) that were modestly (28%) but significantly (p,0.001) higher than Raw among both nonsmoker (NS) and tobacco smoker (TS) controls; similar differences were noted for specific airway conductance (sGaw). These findings suggested that marijuana smoking may cause mild, but significant, narrowing of larger airways not detectable in similarly aged tobacco smokers, but no demonstrable abnormality involving the smaller airways. A later cross-sectional study by the same authors in a Los Angeles convenience sample of young (mean age 34 yrs) heavy MSs (n5144), smokers of both marijuana and tobacco (MTSs; n5135), TSs (n579) and NSs (n597) showed similar results [4], i.e. no abnormalities in spirometric or small airways indices (closing volume, DN 2 750-1250 or measures derived from flowvolume curves obtained with air and a helium-...
This article offers a perspective on the use of volatilized alkaloidal cocaine in its freebase and crack forms and on the pulmonary consequences of such use. The inhalational route of administration of freebase and crack cocaine exposes the lung to their combustion products, raising concern about possible adverse pulmonary effects. A brief historical review of cocaine and its methods of use precedes the presentation of data concerning current modes and patterns of use and some pulmonary complications of crack and freebase use. Results from a systematic study of a large sample of cocaine users document a high frequency of occurrence of acute respiratory symptoms in temporal association with cocaine smoking. No relationship was detected between the prevalence of acute pulmonary symptoms and identifiable aspects of techniques of cocaine administration. These results suggest that the respiratory consequences of alkaloidal cocaine are most likely attributable to the inhaled cocaine itself, rather than to variable characteristics of usage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.